Agency Information Collection Activities: Proposed Collection; Comment Request, 21233-21235 [2017-09090]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
SRADOVICH on DSK3GMQ082PROD with NOTICES
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason, or when a PSO’s listing expires.
AHRQ has accepted a notification of
voluntary relinquishment from the
Empire State Patient Safety Assurance
Network PSO of its status as a PSO, and
has delisted the PSO accordingly.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on March 30, 2017.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
product (PSWP) in its possession. The
PSO will meet the requirements of
Section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO.
In addition, according to Sections
3.108(c)(2)(ii) and 3.108(b)(3) of the
Patient Safety Rule regarding
disposition of PSWP, the PSO has 90
days from the effective date of delisting
and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.ahrq.gov.
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from the Empire State Patient Safety
Assurance Network, PSO, a component
entity of the University of Buffalo, PSO
number P0048, to voluntarily relinquish
its status as a PSO. Accordingly, the
Empire State Patient Safety Assurance
Network, PSO was delisted effective at
12:00 Midnight ET (2400) on March 30,
2017.
Empire State Patient Safety Assurance
Network, PSO has patient safety work
Agency Information Collection
Activities: Proposed Collection;
Comment Request
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09091 Filed 5–4–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project: ‘‘The
AHRQ Safety Program for Improving
Antibiotic Use.’’
DATES: Comments on this notice must be
received by July 5, 2017.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Proposed Project
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
Antibiotics can have serious adverse
effects including Clostridium difficile
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
21233
infections (CDI), organ dysfunction,
allergic reactions, and the development
of antibiotic resistance on both a patient
level and population level. This project
will assist acute care, long-term care and
ambulatory care settings across the
United States in adopting and
implementing antibiotic stewardship
programs, which are coordinated efforts
to improve the use of antibiotics by
promoting the selection of the optimal
antibiotic regimen, dose, route of
administration, and duration of therapy.
More specifically, this project has the
following goals:
• Identify best practices in the delivery
of antibiotic stewardship in the acute
care, long-term care and ambulatory
care settings
• Adapt the Comprehensive Unit-Based
Safety Program (CUSP) model to
enhance antibiotic stewardship efforts
in the health care settings
• Assess the adoption of CUSP for
antibiotic stewardship and evaluate
the effectiveness of the intervention in
the participating health care systems
• Develop a bundle of technical and
adaptive interventions and associated
tools and educational materials
designed to support enhanced
antibiotic stewardship efforts
• Provide technical assistance and
training to health care organizations
nationwide, using a phased approach,
to implement effective antibiotic
stewardship programs and
interventions
• Improve communication and
teamwork between health care
workers surrounding antibiotic
decision-making
• Improve communication between
health care workers and patients/
families surrounding antibiotic
decision-making
This study is being conducted by
AHRQ through its contractor Johns
Hopkins University, with subcontracted
partner NORC. The AHRQ Safety
Program for Improving Antibiotic Use is
being undertaken pursuant to AHRQ’s
mission to enhance the quality,
appropriateness, and effectiveness of
health services, and access to such
services, through the establishment of a
broad base of scientific research and
through the promotion of improvements
in clinical and health systems practices,
including the prevention of diseases and
other health conditions. 42 U.S.C. 299.
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
(1) Structural Assessments: A brief
(five to seven questions), online
E:\FR\FM\05MYN1.SGM
05MYN1
21234
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
Structural Assessment Tool will be
administered in all settings at baseline
(pre-intervention) and at the end of the
intervention period to obtain general
information about facilities and existing
stewardship infrastructure and changes
in stewardship infrastructure and
interventions as a result of the AHRQ
Safety Program.
(2) Team Antibiotic Review Form: The
Stewardship Team will conduct
monthly reviews of at least 10 patients
who received antibiotics and fill out an
assessment tool in conjunction with
frontline staff to determine if the ‘‘four
moments of antibiotic decision-making’’
are being considered by providers. The
four moments can be summarized as:
(1.) Is an infection present requiring
antibiotics? (2.) Were appropriate
cultures ordered and best initial choice
of antibiotics made? (3.) (after at least 24
hours) Are changes in antibiotic orders
appropriate? (4.) What duration of
therapy is appropriate?
(3) The AHRQ Surveys on Patient
Safety Culture will be administered to
all participating staff at the beginning
and end of the intervention. Each survey
asks questions about patient safety
issues, medical errors, and event
reporting in the respective settings.
a. The Hospital Survey on Patient
Safety Culture (HSOPS) will be utilized
to evaluate safety culture for acute care
hospitals.
b. The Nursing Home Survey on
Patient Safety Culture (NHSOPS) will be
administered in long term care.
c. The Medical Office Survey on
Patient Safety Culture (MOSOPS) will
be administered in ambulatory care
centers.
(4) Semi-structured qualitative
interviews: In-person and/or telephone
discussions will be held before and after
implementation with stewardship
champions/organizational leaders,
physicians, pharmacists, nurse
practitioners, physician assistants,
nurses, certified nursing assistants and
others deemed relevant, to learn about
the facilitators and barriers to a
successful antibiotic stewardship
program. Specific areas of interest
include stakeholder perceptions of
implementation process and outcomes,
including successes and challenges with
carrying out project tasks and perceived
utility of the project; staff roles,
engagement and support; and antibiotic
prescribing etiquette & culture (i.e.,
social norms and local cultural factors
that contribute to prescribing behavior
at the facility/unit-level).
(5) Electronic Health Record (EHR)
data: Unit-level antibiotic usage and
clinical outcomes will be extracted from
the EHRs of participating health care
facilities and used to assess the impact
of the AHRQ Safety Program for
Improving Antibiotic Use.
Estimated Annual Respondent Burden
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Hours per
response
Total burden
hours
1. Structural Assessment .................................................................................
2. Team Antibiotic Review Form .....................................................................
3. Surveys on Patient Safety Culture (SOPS):
a. HSOPS .................................................................................................
b. NHSOPS ..............................................................................................
c. MOSOPS ..............................................................................................
4. Semi-structured qualitative interviews .........................................................
(Physicians—line 1; Other Health Practitioners—line 2) ..........................
5. EHR data .....................................................................................................
500
333
2
90
0.2
0.2
200
5,994
4,167
4,167
4,167
30
60
500
2
2
2
2
2
12
.5
.5
.5
1
1
.5
4,167
4,167
4,167
60
120
3,000
Total ..........................................................................................................
13,924
N/A
N/A
21,875
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Form name
Total burden
hours
Average
hourly wage
rate *
Total cost
burden
500
333
200
5,994
a $98.83
4,167
4,167
4,167
30
60
500
4,167
4,167
4,167
60
120
3,000
b 27.87
b 27.87
116,134
116,134
116,134
5,930
3,344
83,610
Total ..........................................................................................................
SRADOVICH on DSK3GMQ082PROD with NOTICES
1. Structural Assessment .................................................................................
2. Team Antibiotic Review Form .....................................................................
3. SOPS:
a. HSOPS .................................................................................................
b. NHSOPS ..............................................................................................
c. MOSOPS ..............................................................................................
4. Semi-structured qualitative interviews .........................................................
(Physicians—line 1; Other Health Practitioners—line 2) ..........................
5. EHR data .....................................................................................................
13,924
21,875
N/A
1,053,439
a 98.83
b 27.87
b 27.87
a 98.83
b 27.87
$19,766
592,387
* National Compensation Survey: Occupational wages in the United States May 2016 ‘‘U.S. Department of Labor, Bureau of Labor Statistics:’’
https://www.bls.gov/oes/current/oes_stru.htm.
a Based on the mean wages for 29–1069 Physicians and Surgeons, All Other.
b Based on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical
Workers, All Other.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
E:\FR\FM\05MYN1.SGM
05MYN1
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09090 Filed 5–4–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality; Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of five AHRQ
subcommittee meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will commence in open session before
closing to the public for the duration of
the meeting. These meetings will be
closed to the public in accordance with
5 U.S.C. App. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6).
DATES: See below for dates of meetings:
1. Health Care Research and Training
(HCRT)
Date: May 25–26, 2017 (Open from
8:00 a.m. to 8:30 a.m. on May 25
and closed for remainder of the
meeting)
2. Healthcare Information Technology
Research (HITR)
Date: June 7–9, 2017 (Open from 6:00
p.m. to 6:30 p.m. on June 7 and
closed for remainder of the meeting)
3. Health System and Value Research
(HSVR)
Date: June 14–15, 2017 (Open from
8:30 a.m. to 9:00 a.m. on June 14
and closed for remainder of the
meeting)
4. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: June 14–15, 2017 (Open from
8:30 a.m. to 9:00 a.m. on June 14
SRADOVICH on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
and closed for remainder of the
meeting)
5. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: June 22–23, 2017 (Open from
8:00 a.m. to 8:30 a.m. on June 22
and closed for remainder of the
meeting)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ADDRESSES:
(Below specifics where each
hotel will be held)
AGENCY:
Gaithersburg Marriott, 9751
Washingtonian Blvd., Gaithersburg,
Maryland 20878.
SUMMARY:
(To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
FOR FURTHER INFORMATION CONTACT:
Mrs. Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20857,
Telephone (301) 427–1554.
BILLING CODE 4160–90–P
21235
SUPPLEMENTARY INFORMATION:
In accordance with section 10 (a)(2) of
the Federal Advisory Committee Act (5
U.S.C. App. 2), AHRQ announces
meetings of the above-listed scientific
peer review groups, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committees. Each subcommittee
meeting will commence in open session
before closing to the public for the
duration of the meeting. The
subcommittee meetings will be closed to
the public in accordance with the
provisions set forth in 5 U.S.C. App. 2
section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6) The grant applications
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09130 Filed 5–4–17; 8:45 am]
BILLING CODE 4160–90–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project ‘‘The Reengineered Visit for Primary Care.’’
This proposed information collection
was previously published in the Federal
Register on February 13, 2017 and
allowed 60 days for public comment.
AHRQ received one comment from the
public. The purpose of this notice is to
allow an additional 30 days for public
comment.
DATES: Comments on this notice must be
received by June 5, 2017.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
email at OIRA_submission@
omb.eop.gov (attention: AHRQ’s desk
officer).
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
The Re-Engineered Visit for Primary
Care
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
This project, The Re-engineered Visit for
Primary Care, directly addresses the
agency’s goal to conduct research to
enhance the quality of health care and
reduce avoidable readmissions, which
are a major indicator of poor quality and
patient safety.
Research from AHRQ’s Healthcare
Cost and Utilization Project (HCUP)
indicates that in 2011 there were
approximately 3.3 million adult hospital
readmissions in the United States.
Adults covered by Medicare have the
highest readmission rate (17.2 per 100
admissions), followed by adults covered
by Medicaid (14.6 per 100 admissions)
and privately insured adults (8.7 per
E:\FR\FM\05MYN1.SGM
05MYN1
]]>Agencies
[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21233-21235]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09090]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``The AHRQ Safety Program for Improving Antibiotic Use.''
DATES: Comments on this notice must be received by July 5, 2017.
ADDRESSES: Written comments should be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by email at
doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3521, AHRQ invites the public to comment on this proposed information
collection. Antibiotics can have serious adverse effects including
Clostridium difficile infections (CDI), organ dysfunction, allergic
reactions, and the development of antibiotic resistance on both a
patient level and population level. This project will assist acute
care, long-term care and ambulatory care settings across the United
States in adopting and implementing antibiotic stewardship programs,
which are coordinated efforts to improve the use of antibiotics by
promoting the selection of the optimal antibiotic regimen, dose, route
of administration, and duration of therapy.
More specifically, this project has the following goals:
Identify best practices in the delivery of antibiotic
stewardship in the acute care, long-term care and ambulatory care
settings
Adapt the Comprehensive Unit-Based Safety Program (CUSP) model
to enhance antibiotic stewardship efforts in the health care settings
Assess the adoption of CUSP for antibiotic stewardship and
evaluate the effectiveness of the intervention in the participating
health care systems
Develop a bundle of technical and adaptive interventions and
associated tools and educational materials designed to support enhanced
antibiotic stewardship efforts
Provide technical assistance and training to health care
organizations nationwide, using a phased approach, to implement
effective antibiotic stewardship programs and interventions
Improve communication and teamwork between health care workers
surrounding antibiotic decision-making
Improve communication between health care workers and
patients/families surrounding antibiotic decision-making
This study is being conducted by AHRQ through its contractor Johns
Hopkins University, with subcontracted partner NORC. The AHRQ Safety
Program for Improving Antibiotic Use is being undertaken pursuant to
AHRQ's mission to enhance the quality, appropriateness, and
effectiveness of health services, and access to such services, through
the establishment of a broad base of scientific research and through
the promotion of improvements in clinical and health systems practices,
including the prevention of diseases and other health conditions. 42
U.S.C. 299.
Method of Collection
To achieve the goals of this project the following data collections
will be implemented:
(1) Structural Assessments: A brief (five to seven questions),
online
[[Page 21234]]
Structural Assessment Tool will be administered in all settings at
baseline (pre-intervention) and at the end of the intervention period
to obtain general information about facilities and existing stewardship
infrastructure and changes in stewardship infrastructure and
interventions as a result of the AHRQ Safety Program.
(2) Team Antibiotic Review Form: The Stewardship Team will conduct
monthly reviews of at least 10 patients who received antibiotics and
fill out an assessment tool in conjunction with frontline staff to
determine if the ``four moments of antibiotic decision-making'' are
being considered by providers. The four moments can be summarized as:
(1.) Is an infection present requiring antibiotics? (2.) Were
appropriate cultures ordered and best initial choice of antibiotics
made? (3.) (after at least 24 hours) Are changes in antibiotic orders
appropriate? (4.) What duration of therapy is appropriate?
(3) The AHRQ Surveys on Patient Safety Culture will be administered
to all participating staff at the beginning and end of the
intervention. Each survey asks questions about patient safety issues,
medical errors, and event reporting in the respective settings.
a. The Hospital Survey on Patient Safety Culture (HSOPS) will be
utilized to evaluate safety culture for acute care hospitals.
b. The Nursing Home Survey on Patient Safety Culture (NHSOPS) will
be administered in long term care.
c. The Medical Office Survey on Patient Safety Culture (MOSOPS)
will be administered in ambulatory care centers.
(4) Semi-structured qualitative interviews: In-person and/or
telephone discussions will be held before and after implementation with
stewardship champions/organizational leaders, physicians, pharmacists,
nurse practitioners, physician assistants, nurses, certified nursing
assistants and others deemed relevant, to learn about the facilitators
and barriers to a successful antibiotic stewardship program. Specific
areas of interest include stakeholder perceptions of implementation
process and outcomes, including successes and challenges with carrying
out project tasks and perceived utility of the project; staff roles,
engagement and support; and antibiotic prescribing etiquette & culture
(i.e., social norms and local cultural factors that contribute to
prescribing behavior at the facility/unit-level).
(5) Electronic Health Record (EHR) data: Unit-level antibiotic
usage and clinical outcomes will be extracted from the EHRs of
participating health care facilities and used to assess the impact of
the AHRQ Safety Program for Improving Antibiotic Use.
Estimated Annual Respondent Burden
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
1. Structural Assessment........................ 500 2 0.2 200
2. Team Antibiotic Review Form.................. 333 90 0.2 5,994
3. Surveys on Patient Safety Culture (SOPS):
a. HSOPS.................................... 4,167 2 .5 4,167
b. NHSOPS................................... 4,167 2 .5 4,167
c. MOSOPS................................... 4,167 2 .5 4,167
4. Semi-structured qualitative interviews....... 30 2 1 60
(Physicians--line 1; Other Health 60 2 1 120
Practitioners--line 2).....................
5. EHR data..................................... 500 12 .5 3,000
---------------------------------------------------------------
Total....................................... 13,924 N/A N/A 21,875
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Average
Form name Number of Total burden hourly wage Total cost
respondents hours rate * burden
----------------------------------------------------------------------------------------------------------------
1. Structural Assessment........................ 500 200 \a\ $98.83 $19,766
2. Team Antibiotic Review Form.................. 333 5,994 \a\ 98.83 592,387
3. SOPS:
a. HSOPS.................................... 4,167 4,167 \b\ 27.87 116,134
b. NHSOPS................................... 4,167 4,167 \b\ 27.87 116,134
c. MOSOPS................................... 4,167 4,167 \b\ 27.87 116,134
4. Semi-structured qualitative interviews....... 30 60 \a\ 98.83 5,930
(Physicians--line 1; Other Health 60 120 \b\ 27.87 3,344
Practitioners--line 2).....................
5. EHR data..................................... 500 3,000 \b\ 27.87 83,610
---------------------------------------------------------------
Total....................................... 13,924 21,875 N/A 1,053,439
----------------------------------------------------------------------------------------------------------------
* National Compensation Survey: Occupational wages in the United States May 2016 ``U.S. Department of Labor,
Bureau of Labor Statistics:'' https://www.bls.gov/oes/current/oes_stru.htm.
\a\ Based on the mean wages for 29-1069 Physicians and Surgeons, All Other.
\b\ Based on the mean wages for 29-9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare
Practitioners and Technical Workers, All Other.
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ health care research and
health care information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of
[[Page 21235]]
AHRQ's estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information upon the
respondents, including the use of automated collection techniques or
other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-09090 Filed 5-4-17; 8:45 am]
BILLING CODE 4160-90-P
